Your browser doesn't support javascript.
loading
Stem cells. m6A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation.
Geula, Shay; Moshitch-Moshkovitz, Sharon; Dominissini, Dan; Mansour, Abed AlFatah; Kol, Nitzan; Salmon-Divon, Mali; Hershkovitz, Vera; Peer, Eyal; Mor, Nofar; Manor, Yair S; Ben-Haim, Moshe Shay; Eyal, Eran; Yunger, Sharon; Pinto, Yishay; Jaitin, Diego Adhemar; Viukov, Sergey; Rais, Yoach; Krupalnik, Vladislav; Chomsky, Elad; Zerbib, Mirie; Maza, Itay; Rechavi, Yoav; Massarwa, Rada; Hanna, Suhair; Amit, Ido; Levanon, Erez Y; Amariglio, Ninette; Stern-Ginossar, Noam; Novershtern, Noa; Rechavi, Gideon; Hanna, Jacob H.
Afiliação
  • Geula S; The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
  • Moshitch-Moshkovitz S; Cancer Research Center, Chaim Sheba Medical Center, Tel Hashomer, Israel, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Dominissini D; Department of Chemistry and Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL 60637, USA.
  • Mansour AA; The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
  • Kol N; Cancer Research Center, Chaim Sheba Medical Center, Tel Hashomer, Israel, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Salmon-Divon M; Cancer Research Center, Chaim Sheba Medical Center, Tel Hashomer, Israel, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Hershkovitz V; Cancer Research Center, Chaim Sheba Medical Center, Tel Hashomer, Israel, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Peer E; Cancer Research Center, Chaim Sheba Medical Center, Tel Hashomer, Israel, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Mor N; The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
  • Manor YS; The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
  • Ben-Haim MS; Cancer Research Center, Chaim Sheba Medical Center, Tel Hashomer, Israel, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Eyal E; Cancer Research Center, Chaim Sheba Medical Center, Tel Hashomer, Israel, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Yunger S; Cancer Research Center, Chaim Sheba Medical Center, Tel Hashomer, Israel, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Pinto Y; Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel.
  • Jaitin DA; The Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Viukov S; The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
  • Rais Y; The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
  • Krupalnik V; The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
  • Chomsky E; The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
  • Zerbib M; The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
  • Maza I; The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
  • Rechavi Y; The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
  • Massarwa R; The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
  • Hanna S; The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. The Department of Pediatrics and the Pediatric Immunology Unit, Rambam Medical Center, and the B. Rappaport Faculty of Medicine, Technion, Haifa, Israel.
  • Amit I; The Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Levanon EY; Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel.
  • Amariglio N; Cancer Research Center, Chaim Sheba Medical Center, Tel Hashomer, Israel, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel.
  • Stern-Ginossar N; The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
  • Novershtern N; The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. jacob.hanna@weizmann.ac.il noa.novershtern@weizmann.ac.il gidi.rechavi@sheba.health.gov.il.
  • Rechavi G; Cancer Research Center, Chaim Sheba Medical Center, Tel Hashomer, Israel, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. jacob.hanna@weizmann.ac.il noa.novershtern@weizmann.ac.il gidi.rechavi@sheba.health.gov.il.
  • Hanna JH; The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. jacob.hanna@weizmann.ac.il noa.novershtern@weizmann.ac.il gidi.rechavi@sheba.health.gov.il.
Science ; 347(6225): 1002-6, 2015 Feb 27.
Article em En | MEDLINE | ID: mdl-25569111
ABSTRACT
Naïve and primed pluripotent states retain distinct molecular properties, yet limited knowledge exists on how their state transitions are regulated. Here, we identify Mettl3, an N(6)-methyladenosine (m(6)A) transferase, as a regulator for terminating murine naïve pluripotency. Mettl3 knockout preimplantation epiblasts and naïve embryonic stem cells are depleted for m(6)A in mRNAs, yet are viable. However, they fail to adequately terminate their naïve state and, subsequently, undergo aberrant and restricted lineage priming at the postimplantation stage, which leads to early embryonic lethality. m(6)A predominantly and directly reduces mRNA stability, including that of key naïve pluripotency-promoting transcripts. This study highlights a critical role for an mRNA epigenetic modification in vivo and identifies regulatory modules that functionally influence naïve and primed pluripotency in an opposing manner.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA Mensageiro / Diferenciação Celular / Adenosina / Células-Tronco Pluripotentes / Metiltransferases Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA Mensageiro / Diferenciação Celular / Adenosina / Células-Tronco Pluripotentes / Metiltransferases Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article